Examination of U-87 and U-251 GBM cells revealed that the 2-DG and WP1122 treatments dose- and time-dependently exerted cytotoxic effects, as examined with the MTS viability (Figure 1), BrdU proliferation (Figure 2), and SRB protein synthesis (Figure 3) assays. Here, CCT4 is linked to glioblastoma.